Company intelligence / Profile preview
Chameleon Biosciences
Berkeley, California, United Stateschameleonbiosci.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Pre-clinical stage gene therapy platform showing increased potency, reduced immune response, and repeat dosing potential in mouse and non-human primate models.[2]
- Therapeutic areas
- HematologyRare Diseases
- Modalities
- Gene therapy
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
CureDuchenne
Beyond the preview
Go deeper on Chameleon Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chameleon Biosciences.